Taking India's fight to contain the Novel Coronavirus to the next stage, the Indian Council of Medical research (ICMR) on Saturday (4 April) issued the advisory to initiate the rapid antibody based testing for COVID-19 in all areas reporting clusters, and also in case of large migration gatherings or evacuee centres, Economic Times.
Presently the government uses RT-Polymerse Chain Reaction (PCR) tests to decipher if an individual has contracted the virus. The test takes a long time to give the confirmation. On the other hand, the antibody test is likely to help shorten the time to just 15-30 minutes.
If the antibody test comes out positive, then a clinical assessment is a mandatory step, to be followed by hospitalisation or isolation as per the protocol in place. However, if the test comes negative, then if warranted, the patient can also be subjected through RT-PCR test using the throat or nasal swab.
The advisory comes as the number of confirmed cases of COVID-19 in India crossed the 3,000 count yesterday (5 April). The pandemic has already led to 75 deaths.
The advisory to initiate the rapid testing based on antibody detection was taken by the National Task Force in an emergency meeting which was held recently. The National Task Force is headed by the Director of AIIMS, Delhi Dr Randeep Guleria who is also a Padma Shri recipient.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.